Sigrima 420Mg Inj

About Sigrima 420Mg Inj

Pertuzumab Injection is a targeted monoclonal antibody used in the treatment of HER2-positive breast cancer. It works by binding to the HER2 receptor on cancer cells, inhibiting cell growth and preventing tumor progression. Pertuzumab is commonly administered in combination with Trastuzumab and chemotherapy to enhance therapeutic effectiveness in both early and metastatic breast cancer cases. Composition:Pertuzumab (Recombinant Humanized Monoclonal Antibody) Indications: HER2-positive breast cancer Metastatic breast cancer Neoadjuvant and adjuvant breast cancer therapy Mechanism of Action:Pertuzumab blocks the dimerization of the HER2 receptor with other HER family receptors, thereby interrupting cancer cell signaling pathways and slowing tumor growth. Dosage & Administration: Administered intravenously (IV infusion) Dosage as prescribed by a qualified oncologist Used in combination therapy as per clinical protocol Storage Instructions: Store at 2C to 8C Do not freeze Protect from light Precautions: To be administered under medical supervision only Monitor cardiac function during treatment Not recommended for pregnant or breastfeeding women unless advised by a physician Packaging:Vial / Injection (strength as per availability) Quality Assurance: WHO-GMP certified manufacturing Stringent quality control and safe packaging